David S. Block
CEO
Department of biopharmaceuticals
gliknik
United States of America
Biography
Dr. David S. Block, MD, MBA founded Gliknik, Inc. in 2007 and serves as its Chief Executive Officer and Chairman. Dr. Block founded Psyadon Pharmaceuticals, Inc. (formerly, Ruxton Pharmaceuticals, Inc.) in 2004 and served as its Chief Executive Officer, President & Chief Operating Officer. He served as President of Gliknik Inc. He served as the Executive Vice President of International Operations at the time of the sale of DuPont Pharmaceuticals to Bristol-Myers Squibb.
Research Interest
BIopharmaceuticals